usefulness of I-FABP in the surgical managment of small bowel obstruction caused by adhesions.
ID
Source
Brief title
Condition
- Gastrointestinal stenosis and obstruction
- Gastrointestinal therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
I-FABP values in blood and urine, radiological findings, decision for surgery.
Secondary outcome
Spontaneous recovery, therapeutic effect water-soluble contrast
Background summary
Small bowel obstruction due to adhesions forms a large part of postoperative
morbidity in Western countries. In the management of small bowel obstruction it
is often said to "never let the sun rise or set on small-bowel obstruction"
because they are sometimes fatal if treatment is delayed. This traditional
surgical canon is no longer followed, since for a large group of patients it is
unclear who can be treated conservatively, and in which cases a surgical
intervention is needed. Unnecessary surgical intervention needs to be avoided
since this is accompanied with risks of intestinal damage, anastomotic leakage
in case of resection and a prolonged postoperative ileus afterwards.
Water-soluble contrast such as gastrograffin may aid in the management of small
bowel obstruction due to adhesions as both a diagnostic tool and a therapeutic
tool (it is a laxative). Also a CT-scan of the abdomen may help to better
differentiate between those patients taht can be treated conservatively and
patients that need surgery. Despite these different diagnostic modalities,
timing and decision for surgery remains an important clinical problem. A
combination of clinical symptoms, experience of the surgeon and radiologic
findings ultimately result in the final decision. Patients that require
surgery for small bowel obstruction often have a longer period of strangulation
of the small bowel leading to intestinal damage. A marker with sufficient
sensitivity and specificity for intestinal damage may be of importance in
selection of patients with small bowel obstruction for surgery.
Intestinal-Fatty Acid Binding Protein (I-FABP) is a cytosolic protein that
resides in the intestinal epithelium and is released in the blood following
intestinal damage. In previous experimental and clinical studies has been shown
that I-FABP is strongly associated with the intestinal damage and is increased
in mesenteric ischemia. We hypothesize that increased levels of I-FABP aid in
the surgical management of small bowel obstruction.
Study objective
usefulness of I-FABP in the surgical managment of small bowel obstruction
caused by adhesions.
Study design
Blood and urine will be sampled at time of diagnosis (day 0) untill three days
afterwards. I-FABP values will be compard with clinical outcome and
radiological findings.
Study burden and risks
Venous puncture will be performed, in total 4 times. This will be in most cases
part of regular blood sampling. Collection of urine is without risks.
Benefit: This study will aid in a more adequate surgical management of small
bowel obstruction.
Michelangelolaan 2
Eindhoven 5623EJ
NL
Michelangelolaan 2
Eindhoven 5623EJ
NL
Listed location countries
Age
Inclusion criteria
1. Age >18 years
2. diagnosis of small bowel obstruction based on adhesions (at least 1 abdominal surgerical event in the history)
3. signed informed consent
Exclusion criteria
1. patients unfit for surgery
2. Patients that are unable to undergo a CT
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL37278.060.11 |